Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 29.45
+0.15 (0.51%)
Oct 31, 2025, 1:30 PM CST
Medigen Biotechnology Revenue
Medigen Biotechnology had revenue of 360.78M TWD in the quarter ending June 30, 2025, with 1.88% growth. This brings the company's revenue in the last twelve months to 1.63B, up 16.80% year-over-year. In the year 2024, Medigen Biotechnology had annual revenue of 1.37B with 18.57% growth.
Revenue (ttm)
1.63B
Revenue Growth
+16.80%
P/S Ratio
2.52
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.37B | 214.98M | 18.57% |
| Dec 31, 2023 | 1.16B | 101.77M | 9.64% |
| Dec 31, 2022 | 1.06B | -2.87B | -73.08% |
| Dec 31, 2021 | 3.92B | 3.31B | 537.17% |
| Dec 31, 2020 | 615.54M | 63.20M | 11.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |